Abbott Laboratories develops, manufactures, and sells medical devices for cardiovascular care and diabetes management, adult and pediatric nutrition products, diagnostic instruments and test kits, and branded generic pharmaceuticals. Its portfolio includes pacemakers, implantable cardioverter-defibrillators, neuromodulation systems, coronary stents, catheters, infant formula, adult nutritional beverages, continuous glucose monitoring systems, as well as immunoassay and point-of-care diagnostic solutions. Approximately 60% of Abbott’s revenue comes from markets outside the United States.